1-5 of 5
Andrea Baran
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Increased Risk of Toxicity with Novel PI3K Delta Inhibitor Combinations Compared with Standard Use in Non-Hodgkin Lymphoma Patients

Annalynn Williams, MS, Elizabeth Baloga, Andrea Baran, MS, Margaret Helber, PharmD, Jeremiah Moore, PharmD, Carla Casulo, MD, Patrick M. Reagan, MD, Jonathan W. Friedberg, MD, Clive S Zent, MD, Paul M. Barr, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4050.
https://doi.org/10.1182/blood.V130.Suppl_1.4050.4050
Published: 2017
Journal Articles

Tissue Factor-Related Biomarkers and Prediction of Cancer-Associated VTE: Correlative Analyses of the Phacs Trial

Alok A. Khorana, MD, Nigel Mackman, PhD, Yohei Hisada, PhD, Cihan Ay, MD, Derick Peterson, Charles W. Francis, MD, Andrea Baran, MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 1096.
https://doi.org/10.1182/blood.V130.Suppl_1.1096.1096
Published: 2017
Journal Articles

Consolidative Radioimmunotherapy after Chemoimmunotherapy in Patients with Histologic Transformation of Indolent Lymphoma

Patrick M. Reagan, MD, Jennifer L. Kelly, PhD MPH, Andrea Baran, MS, Paul M. Barr, MD, Carla Casulo, MD, Vaseem Chengazi, MD PhD, Jonathan W. Friedberg, MD MMSc
Journal: Blood
Blood (2014) 124 (21): 1746.
https://doi.org/10.1182/blood.V124.21.1746.1746
Published: 2014
Journal Articles

Outpatient Administration of High Dose BEAM Chemotherapy As Conditioning for Autologous Stem Cell Transplantation for Lymphoma Results in Fewer Infectious Complications and Improved Survival

Robin M. Reid, MD, Andrea Baran, MS, Paul M. Barr, MD, Michael W. Becker, MD, Steven H. Bernstein, MD, Jonathan W. Friedberg, MD, Jane L. Liesveld, MD, Gordon L. Phillips, MD, Lucy Wedow, FNP, Laurie A. Milner, MD
Journal: Blood
Blood (2014) 124 (21): 3984.
https://doi.org/10.1182/blood.V124.21.3984.3984
Published: 2014
Journal Articles

Redox Associated Gene Expression Predicts For Responses To The Pro-Oxidant Molecule Imexon In Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma: Results Of a Multi-Center Phase II Study

Paul M. Barr, MD, Margaret M. Briehl, PhD, Steven H Bernstein, MD, Jonathan W. Friedberg, MD, Andrea Baran, MS, Derick R. Peterson, PhD, Daniel Oscar Persky, MD, Carla Casulo, MD, Megan M. Herr, BS, Jamie Littleton, BSN, Erin Cebula, MPH, CCRP, Mark Schwartz, PhD, Soham D. Puvvada, MD, Robert T Dorr, PhD, Richard I Fisher, MD, Thomas P. Miller, MD
Journal: Blood
Blood (2013) 122 (21): 89.
https://doi.org/10.1182/blood.V122.21.89.89
Published: 2013